For today’s biopharmaceutical manufacturers, time is of the essence. Any delay in the process — from overcoming supply chain obstacles and procuring materials to ensuring your finished drug product is delivered to patients — is not only costly but could be detrimental for those who need it most.
To mitigate risk, companies often partner with a CMO who can seamlessly navigate the process. CMOs have a direct impact on product quality, integrity, supply continuity and even cost – with the potential to constrain a company’s growth or add significant value.
Once you've formed a partnership, how do you ensure success? The secret: planning as early as possible – while your product is still in preclinical or clinical development.
Discover the top three considerations as you begin to plan with your CMO partner.